Trial Design:

• How can I assess the impact of my I/E criteria on the target patient population?
• What does the patient journey look like for my target population? Comorbidities? Line of therapy? Adherence?

Site and Investigator Selection:

• Which “trial-ready” sites have screening-eligible AND representative target patients? 
• Who are potential investigators with trial experience currently treating my target patient population? 

Trial Recruitment:

• How do I identify and intervene at key points of the patient journey specific to different racial and ethnic groups?
• What are the patient referral pathways, and what are the ideal sites to consider for my recruitment strategy?

Evidence Generation:

• Who is the right RWD partner to support my trial studies demonstrating long-term safety and efficacy? PurpleLab.